LCTX Operating Cash Flow (Statement)

Lineage Cell Therapeutics, Inc. Common Stock · Operating Cash Flow (Statement)

LCTX logo

LCTX Operating Cash Flow (Statement)

Latest reported-$7.24M
LCTX Quarterly Cash from Operations (-$100.00K → -$7.24M)
High-resolution chart · PNG

LCTX operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
-7,244,000
-8,077,999
-4,878,000
-3,616,000
-5,539,000
-4,886,000
-6,346,000
-5,787,000
-5,176,000
-5,783,000
-6,019,000
-5,037,000
-6,268,000
-11,242,000
-8,303,000
-5,480,000
-7,062,000
21,904,000
-5,873,000
-4,848,000
-5,416,000
-7,424,000
-5,641,000
-4,847,000
-4,239,000
-5,026,000
-5,523,000
-7,443,000
-9,667,000
-9,314,000
-5,812,000
-7,332,000
-7,400,000
-10,338,000
-5,675,000
-7,681,000
-9,063,000
-8,098,000
-8,852,000
-8,915,000
-10,246,000
-14,313,000
-13,947,000
-11,561,000
-9,967,179
-9,068,821
-9,110,192
-8,608,759
-10,777,978
-10,357,271
-8,626,934
-6,416,440
-7,443,557
-7,021,682
-4,996,078
-5,008,761
-3,957,745
-5,716,934
-3,595,616
-3,595,394
-2,795,467
-3,607,439
-2,777,103
-1,998,900
-1,730,300
-1,226,581
-845,569
-1,457,856
-930,728
-1,025,785
-511,684
-319,079
-503,233
-270,249
-354,502
-153,482
-350,038
-381,958
-189,815
-237,940
-89,710
-744,754
348,878
-660,804
-443,226
-658,996
-198,083
-182,283
-386,982
-769,348
-464,351
531,140
-160,020
-560,913
-512,800
-464,898
-486,179
-665,278
-284,023
-1,106,190
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.